Biocept Stock Cash Per Share
| BIOCDelisted Stock | USD 1.45 0.17 13.28% |
Biocept fundamentals help investors to digest information that contributes to Biocept's financial success or failures. It also enables traders to predict the movement of Biocept Stock. The fundamental analysis module provides a way to measure Biocept's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biocept stock.
Biocept |
Biocept Company Cash Per Share Analysis
Biocept's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Biocept Cash Per Share | 1.63 X |
Most of Biocept's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biocept is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Biocept has a Cash Per Share of 1.63 times. This is 62.53% lower than that of the Biotechnology sector and 55.46% lower than that of the Health Care industry. The cash per share for all United States stocks is 67.47% higher than that of the company.
Biocept Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biocept's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biocept could also be used in its relative valuation, which is a method of valuing Biocept by comparing valuation metrics of similar companies.Biocept is currently under evaluation in cash per share category among its peers.
Biocept Fundamentals
| Return On Equity | -1.87 | |||
| Return On Asset | -0.52 | |||
| Operating Margin | (10.38) % | |||
| Current Valuation | 5.92 M | |||
| Shares Outstanding | 2.63 M | |||
| Shares Owned By Insiders | 9.20 % | |||
| Shares Owned By Institutions | 1.98 % | |||
| Number Of Shares Shorted | 29.73 K | |||
| Price To Earning | 5.34 X | |||
| Price To Book | 0.37 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 25.86 M | |||
| Gross Profit | (2.58 M) | |||
| EBITDA | (31.98 M) | |||
| Net Income | (32.09 M) | |||
| Cash And Equivalents | 27.57 M | |||
| Cash Per Share | 1.63 X | |||
| Total Debt | 12.11 M | |||
| Debt To Equity | 0.33 % | |||
| Current Ratio | 3.38 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (13.29 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (48.17) X | |||
| Price To Earnings To Growth | (0.04) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 50 | |||
| Beta | 0.6 | |||
| Market Capitalization | 1.14 M | |||
| Total Asset | 30.87 M | |||
| Retained Earnings | (298.44 M) | |||
| Working Capital | 10.84 M | |||
| Current Asset | 9.64 M | |||
| Current Liabilities | 3.34 M | |||
| Z Score | -15.64 | |||
| Net Asset | 30.87 M |
About Biocept Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biocept's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocept using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocept based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Biocept Stock
If you are still planning to invest in Biocept check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biocept's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |